Eagle Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>EP</div>
EGRX -- USA Stock  

USD 46.09  0.46  1.01%

Eagle Stock News module provides quick insight into current market opportunities from investing in Eagle Pharmaceuticals. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Eagle Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Continue to Eagle Pharmaceuticals Hype Analysis, Eagle Pharmaceuticals Correlation and Eagle Pharmaceuticals Performance.

Search Today's Stock News

 
Refresh
Eagle Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Eagle daily returns and investor perception about the current pice of Eagle Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Robert Glenning of 10000 shares of Eagle Pharmaceuticals subject to Rule 16b-3
Filed transaction by Eagle Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Eagle insider trading alert for grant of stock option (right to buy) by Robert Glenning, the corporate stakeholder, on 28th of August 2020. This event was filed by Eagle Pharmaceuticals Inc with SEC on 2018-01-09. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Revenue

Revenue Comparative Analysis

Eagle Pharmaceuticals is rated # 4 in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Peers

Eagle Pharmaceuticals Related Equities

ELANElanco Animal Health   2.34   
0%
25.0%
FLXNFlexion Therapeutics   1.22   
0%
13.0%
EGRXEagle Pharmaceuticals   1.01   
0%
11.0%
BHCBausch Health Companies   0.50   
5.0%
0%
EVOKEvoke Pharma   1.38   
15.0%
0%
ENDPEndo International Plc   1.44   
15.0%
0%
EOLSEvolus Inc Common   1.81   
19.0%
0%
DRRXDURECT   4.28   
47.0%
0%
ACBAurora Cannabis   9.09   
100.0%
0%
Continue to Eagle Pharmaceuticals Hype Analysis, Eagle Pharmaceuticals Correlation and Eagle Pharmaceuticals Performance. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.